Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the Pharmaceuticals and Other segments. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Other segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.
Company profile
Ticker
SNPHY, SNPHF
Exchange
Website
CEO
Akira Kurokawa
Employees
Location
SEC CIK
SNPHY stock data
Latest filings (excl ownership)
F-6EF
Automatic registration for ADRs (foreign)
22 Nov 19
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
29 Sep 17
F-6EF
Automatic registration for ADRs (foreign)
7 Mar 16
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
15 Apr 15
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
30 Mar 15
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
24 Mar 15
F-6EF
Automatic registration for ADRs (foreign)
16 Oct 14
F-6EF
Automatic registration for ADRs (foreign)
1 Feb 13
F-6EF
Automatic registration for ADRs (foreign)
30 Jan 13
F-6EF
Automatic registration for ADRs (foreign)
10 Sep 10
Latest ownership filings
No filings
Institutional ownership, Q4 2021
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|